Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Balamurugan Tangiisuran, Ph.D.

Concepts (140)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists320202601.210 Why?
Malaysia1520221071.080 Why?
Community Pharmacy Services12020510.670 Why?
Health Knowledge, Attitudes, Practice3202040580.670 Why?
Household Products12018260.630 Why?
Nonprescription Drugs120201190.630 Why?
Accidents120181640.580 Why?
Poisoning120182540.560 Why?
Nursing Staff120171130.520 Why?
Medication Therapy Management120171310.510 Why?
Pesticides120182960.510 Why?
Intention120183460.500 Why?
Inappropriate Prescribing220142110.450 Why?
Long-Term Care120176290.410 Why?
Medication Adherence3201921920.400 Why?
Respiratory Tract Infections1202010080.390 Why?
Hypoglycemia120198960.390 Why?
Anti-Bacterial Agents2202074780.370 Why?
Delphi Technique120158930.360 Why?
Hyperglycemia1201913930.350 Why?
Poisons22022370.340 Why?
Nursing Homes2201410840.310 Why?
Attitude of Health Personnel4201739250.300 Why?
Guideline Adherence2201522430.280 Why?
Nigeria220207820.270 Why?
Hypoglycemic Agents1201931100.260 Why?
Hospitalization52016108080.260 Why?
Physicians2202145880.250 Why?
Renal Insufficiency, Chronic1201923100.240 Why?
Caregivers1201723070.230 Why?
Disease Management1201525350.230 Why?
Cross-Sectional Studies92020263180.210 Why?
Models, Theoretical1201435640.200 Why?
Diabetes Mellitus, Type 232020122400.180 Why?
Emergency Service, Hospital2202078750.180 Why?
Drug Prescriptions2201016620.180 Why?
Adverse Drug Reaction Reporting Systems220174970.170 Why?
Nicotinic Agonists120222660.170 Why?
Polypharmacy120213060.160 Why?
Legislation, Drug120202170.140 Why?
Drugs, Chinese Herbal120191420.140 Why?
Substance Withdrawal Syndrome120226240.140 Why?
Algorithms22017140710.120 Why?
Homes for the Aged120172730.120 Why?
Perception2201912050.120 Why?
Antidepressive Agents2201728970.110 Why?
Sex Distribution1201822630.110 Why?
Quality of Life22019134620.110 Why?
Aged1320211711170.100 Why?
Male1820203636980.100 Why?
Needs Assessment1201811380.100 Why?
Databases as Topic120144710.100 Why?
Nutritional Support120141780.100 Why?
Inpatients3201725640.100 Why?
Humans2620227659680.100 Why?
Female1820203961120.100 Why?
Geriatric Assessment2201714290.090 Why?
Prevalence32019158420.090 Why?
General Practitioners120121050.090 Why?
Professional Competence120144290.090 Why?
Heart Failure12015118400.090 Why?
Nutrition Assessment120147380.090 Why?
Medication Reconciliation120121530.090 Why?
Qualitative Research1202131390.090 Why?
Aged, 80 and over72017594890.080 Why?
Patient Education as Topic1201923340.080 Why?
Depressive Disorder, Major2201748080.080 Why?
Hospitals, University120105740.080 Why?
Retrospective Studies82022815140.070 Why?
Stroke2202097470.070 Why?
Antihypertensive Agents2202020330.070 Why?
Europe1201434230.070 Why?
Hospitals, Teaching1201211580.070 Why?
Malnutrition120146290.070 Why?
Prospective Studies52020548020.070 Why?
Brain Ischemia1202030000.070 Why?
Pilot Projects1202087330.070 Why?
Drug Utilization1201211870.060 Why?
Risk Factors82020748400.060 Why?
Middle Aged920202230090.060 Why?
Follow-Up Studies22019391930.060 Why?
Continuity of Patient Care1201210780.060 Why?
Primary Health Care1202147360.060 Why?
Comorbidity22019105630.060 Why?
Incidence22020214800.060 Why?
Patient Discharge2201634610.050 Why?
Recurrence3202085010.050 Why?
Risk Assessment42020242820.050 Why?
Multivariate Analysis12014120560.050 Why?
Pulmonary Disease, Chronic Obstructive1201632470.050 Why?
Adult720222230440.040 Why?
Anxiety1201646710.040 Why?
Neuropsychological Tests1201471230.040 Why?
Child, Preschool22022425000.040 Why?
Bupropion120223030.040 Why?
Quinoxalines120222960.040 Why?
Benzazepines120223080.040 Why?
Reproducibility of Results22017201240.040 Why?
Epirubicin12019820.040 Why?
Prognosis12019299220.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019118680.040 Why?
Obesity12020130760.040 Why?
Hypertension2202086260.030 Why?
Depression1201682370.030 Why?
Complementary Therapies120194870.030 Why?
Practice Guidelines as Topic1201274250.030 Why?
Fluorouracil1201916480.030 Why?
Pharmaceutical Preparations1202210840.030 Why?
Registries2202082970.030 Why?
Cyclophosphamide1201922280.030 Why?
Educational Status1202025130.030 Why?
Personnel, Hospital120142860.020 Why?
Breast Neoplasms12019210560.020 Why?
Child12020805640.020 Why?
Blood Pressure Monitoring, Ambulatory120122540.020 Why?
Aging1200987310.020 Why?
Myocardial Ischemia1202021280.020 Why?
Hospital Administration120123520.020 Why?
Time Factors22020400650.020 Why?
Life Style1201939260.020 Why?
Health Status1201940800.020 Why?
Treatment Outcome32022651880.020 Why?
Sex Factors12019106030.020 Why?
Nutritional Status1201416200.020 Why?
Smoking1202290810.020 Why?
Medication Errors120107860.010 Why?
Neoplasm Staging12019112060.010 Why?
Longitudinal Studies12019147510.010 Why?
Body Mass Index12020130390.010 Why?
Self Report1201437700.010 Why?
Quality Indicators, Health Care1201218060.010 Why?
Infant, Newborn12022263460.010 Why?
Patient Readmission1201632860.010 Why?
Sensitivity and Specificity12017146520.010 Why?
Hospitals1201438880.010 Why?
Infant12022363860.010 Why?
Cohort Studies12022416490.010 Why?
Disease Progression12016136320.010 Why?
Mass Screening1201454460.010 Why?
Adolescent12022888350.010 Why?
Tangiisuran's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.